Federated Hermes’s Abiomed Inc ABMD Stock Holding History

Federated Hermes’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-56,417	Closed	-$13.9M	–	2326
2022 Q3	$13.9M	Buy	56,417 +15,499	+38%	+$3.81M	0.04%	455
2022 Q2	$10.1M	Sell	40,918 -3,031	-7%	-$750K	0.03%	541
2022 Q1	$14.6M	Sell	43,949 -19,590	-31%	-$6.49M	0.03%	521
2021 Q4	$22.8M	Buy	63,539 +1,964	+3%	+$705K	0.04%	462
2021 Q3	$20M	Sell	61,575 -944	-2%	-$307K	0.04%	470
2021 Q2	$19.5M	Sell	62,519 -8,803	-12%	-$2.75M	0.04%	490
2021 Q1	$22.7M	Sell	71,322 -28,691	-29%	-$9.14M	0.04%	457
2020 Q4	$32.4M	Buy	100,013 +3,596	+4%	+$1.17M	0.07%	338
2020 Q3	$26.7M	Sell	96,417 -42,793	-31%	-$11.9M	0.06%	348
2020 Q2	$33.6M	Sell	139,210 -31,599	-18%	-$7.63M	0.08%	278
2020 Q1	$24.8M	Buy	170,809 +10,936	+7%	+$1.59M	0.07%	294
2019 Q4	$27.3M	Buy	159,873 +46,866	+41%	+$7.99M	0.06%	330
2019 Q3	$20.1M	Buy	113,007 +12,185	+12%	+$2.17M	0.05%	368
2019 Q2	$26.3M	Buy	100,822 +55,453	+122%	+$14.4M	0.06%	299
2019 Q1	$13M	Sell	45,369 -6,846	-13%	-$1.96M	0.03%	470
2018 Q4	$17M	Sell	52,215 -9,237	-15%	-$3M	0.05%	346
2018 Q3	$27.6M	Buy	61,452 +1,669	+3%	+$751K	0.06%	286
2018 Q2	$24.5M	Sell	59,783 -20,980	-26%	-$8.58M	0.07%	216
2018 Q1	$23.5M	Buy	80,763 +12,927	+19%	+$3.76M	0.07%	219
2017 Q4	$12.7M	Buy	67,836 +2,824	+4%	+$529K	0.04%	373
2017 Q3	$11M	Buy	65,012 +36,268	+126%	+$6.11M	0.03%	382
2017 Q2	$4.12M	Sell	28,744 -5,700	-17%	-$817K	0.01%	642
2017 Q1	$4.31M	Buy	34,444 +3,095	+10%	+$387K	0.01%	634
2016 Q4	$3.53M	Sell	31,349 -98,392	-76%	-$11.1M	0.01%	663
2016 Q3	$16.7M	Buy	129,741 +97,256	+299%	+$12.5M	0.05%	300
2016 Q2	$3.55M	Sell	32,485 -21,604	-40%	-$2.36M	0.01%	652
2016 Q1	$5.13M	Buy	54,089 +31,358	+138%	+$2.97M	0.02%	541
2015 Q4	$2.05M	Sell	22,731 -15,153	-40%	-$1.37M	0.01%	862
2015 Q3	$3.51M	Buy	37,884 +3,781	+11%	+$351K	0.01%	671
2015 Q2	$2.24M	Buy	34,103 +9,359	+38%	+$615K	0.01%	891
2015 Q1	$1.77M	Buy	+24,744	New	+$1.77M	0.01%	1005